This is the official podcast channel of the European Association of Urology and the European School of Urology. The EAU Podcast is your source for the latest information across the full urological spectrum. Take your clinical practice to new heights and t
European Association of Urology
In "Episode 6" of the series on "Present and future of diagnostics in prostate cancer", Assoc. Prof. Pawel Rajwa (PL) speaks with Prof. Peter Carroll (US) about the shifting landscape of active surveillance for intermediate-risk prostate cancer.Traditionally reserved for low-risk cases, active surveillance is now being considered for select patients with grade group 2 disease - especially when diagnosed through advanced techniques like MRI-targeted biopsy.Prof. Carroll explains how MRI has changed both the decision-making process and the biopsy approach, helping identify candidates with low risk of progression. The conversation addresses the potential to reduce overtreatment, minimise invasive follow-ups, and improve quality of life without compromising outcomes. Together, they examine how emerging data and imaging innovations are informing a more nuanced, patient-specific approach to prostate cancer care.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In "Episode 5" of the series on "Present and future of diagnostics in prostate cancer," Assoc. Prof. Henkjan Huisman (NL) and Dr. Alexander Ng (GB) discuss the exciting, yet controversial topic of artificial intelligence (AI) in prostate cancer diagnosis.They examine where AI currently stands in the diagnostic pathway, including its role alongside MRI-guided biopsies. The discussion covers the progress AI has made in improving accuracy and efficiency in detecting prostate cancer, while also addressing the limitations and challenges that still exist.The episode raises important questions about whether AI is truly transformative or if the excitement around it is just hype, offering a balanced view on its present and future impact in prostate cancer diagnostics.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this panel discussion, UROONCO RCC associate editor Dr. Teele Kuusk talks to EAU RCC guidelines panel members Prof. Axel Bex and Assoc. Prof. Saeed Dabestani on the 2025 updates in the EAU Guidelines for renal cell carcinoma (RCC). Their conversation includes the impact of KEYNOTE-564 on adjuvant therapy, recommendations for stereotactic body radiotherapy (SBRT), surgical approaches, systemic therapies for papillary RCC, and new trial data. They also share insights into ongoing research on liquid biomarkers and perioperative treatment strategies.
In "Episode 4" of the series on "Present and future of diagnostics in Prostate Cancer", Dr. Rossella Nicoletti (IT) and Prof. Eva Compérat (FR) present the case against renaming Gleason score 6 Prostate Cancer.They discuss the strong pathological arguments for keeping the "cancer" designation, pointing to the morphological and molecular evidence that supports this classification. Prof. Comperat highlights the risks of causing confusion within the clinical and research communities if Gleason score 6 were no longer considered cancer.The episode also addresses the potential impact on prostate cancer reporting and the broader implications for treatment decision-making. This discussion presents a compelling counterpoint to the proposal of renaming Gleason score 6, emphasising the importance of consistency in cancer classification.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
The panel chair of the EAU guidelines on MIBC, Assoc. Prof. A. Van Der Heijden discusses the new updates with panel members Dr. L. Mertens and Prof. P. Mariappan.You can view the newest Muscle-invasive and Metastatic Bladder Cancer EAU Guidelines, or download EAU Guidelines App. The app helps to optimise your search with interactive tools to quickly get the answer you need from the best-practice clinical guidelines for urologists. EAU members get full access, and non-members can explore with a 30-day free trial.
In "Episode 3" of the series on "Present and future of diagnostics in prostate cancer", Assoc. Prof. Paweł Rajwa (PL) and Prof. Scott Eggener (US) engage in a thought-provoking discussion about renaming Gleason 6 (Grade Group 1) prostate cancer.The episode digs into the reasons why many experts believe this change is necessary, and the potential benefits it could bring to clinical practice, particularly in reducing overdiagnosis/overtreatment and improving patient outcomes. Prof. Eggener discusses the argument that Gleason 6 (Grade Group 1) might not behave like typical cancer, as it rarely leads to metastasis or death, and that renaming it could positively guide management decisions, particularly with active surveillance.The conversation touches on the implications of this change on prostate cancer screening and how it could alter the way clinicians approach diagnosis and treatment in the future.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
At the American Urological Association's 2025 Annual Meeting in Las Vegas, Dr. Félix Guerrero-Ramos (ES) presented the first results from cohort 4 of the SunRISe-1 study, assessing TAR-200 monotherapy in patients with Bacillus Calmette-Guérin (BCG) - unresponsive papillary-only high-risk non-muscle-invasive bladder cancer.In this episode, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Dr. Guerrero-Ramos about the study's design, a detailed discussion of the results, comparisons with other trials such as BOND-003, and the implications for clinical practice. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
At the 2025 American Urological Association (AUA2025) Meeting in Las Vegas, UROONCO RCC associate editor Dr. Riccardo Bertolo (IT) spoke with Prof. Riccardo Autorino (US) about multi-port and single-port surgery options for kidney cancer. Prof. Autorino shares expert insights on the key features of both surgical platforms, discussing their advantages and disadvantages, as well as considerations for selecting the most suitable patients for each approach.For more updates on kidney cancer, please visit our educational platform UROONCO RCC.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
At the 2025 American Urological Association (AUA 2025) Meeting in Las Vegas, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Dr. Neal Shore (US) about the CREST study results: Sasanlimab in combination with bacillus calmette-guérin (BCG) improves event-free survival (EFS) versus bacillus calmette-guérin as standard of care in high-risk non- muscle-invasive bladder cancer (NMIBC). Dr. Shore explains the study rational, the results of the study, and the take home messages he presented during the meeting.
UROONCO PCa chief editor Dr. Giancarlo Marra talks to Prof. Phil Cornford on the updated EAU Prostate Cancer Guidelines for 2025, specifically on diagnosis and localised disease.Their conversation focuses on key updates in active surveillance, diagnosis, and treatment of localised disease.
In "Episode 2" of the series on "Present and future of diagnostics in prostate cancer," Prof. Monique Roobol (NL) and Dr. Tamás Fazekas (HU) review the ongoing debate surrounding prostate cancer screening.They review the history and development of screening strategies, including the key findings from early trials and the progression toward more personalised, risk-stratified approaches.Prof. Roobol discusses the significance of PSA testing and how it serves as a tool for initial risk stratification, while also addressing the role of advanced techniques like MRI and novel biomarkers in improving screening accuracy. The episode also highlights the need to balance the benefits of early detection with the risks of overdiagnosis, and the speakers share their insights into how the latest clinical trials are shaping the future of prostate cancer screening.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In "Episode 1" of the series "Present and future of diagnostics in prostate cancer," Assoc. Prof. Juan Gomez Rivas (ES) and Dr. Elena Castro (ES) explore the importance of genomics and biomarkers in localised prostate cancer.The episode reviews why these diagnostic tools are pivotal in the changing landscape of prostate cancer, offering a deeper understanding of their current and future role in patient care.Assoc. Prof. Gomez Rivas and Dr. Castro discuss how these advancements in molecular profiling and biomarker testing can revolutionise the diagnosis and management of prostate cancer. Their conversation highlights the evolving nature of prostate cancer diagnosis, offering valuable perspectives on how genomics and biomarkers are shaping the future of personalised treatment strategies.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this episode of EAU Podcasts, Prof. Guy Bogaert and Prof. Christian Radmayr, the vice-chair and chair of the Paediatric Urology Guidelines Panel, discuss the latest updates to the EAU Guidelines on paediatric urology. Tune in to learn about the 2025 updates.
In ‘Episode 4' of the series “Effective performance and personal success”, Assoc. Prof. Juan Luis Vasquez (DK) and Mr. Jason Howlett (DK) explore habit formation and its impact on personal and professional growth.They discuss how consistent actions lead to significant long-term results, offering insights into how habits are formed and sustained. This episode explores strategies for reinforcing positive behaviours, overcoming obstacles to habit change, and using science-backed techniques to make new routines stick.Join us to learn how to take control of your habits and build a foundation for lasting success.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In ‘Episode 3' of the series “Effective performance and personal success”, Assoc. Prof. Juan Luis Vasquez (DK) and Mr. Jason Howlett (DK) explore the role of attention management in maintaining productivity and achieving personal success.They discuss practical strategies to enhance focus, reduce distractions, and create an environment that supports deep work. The episode also covers techniques for managing digital interruptions, sustaining concentration over long periods, and structuring tasks to align with cognitive energy levels.Join us for an insightful conversation on how to take control of your attention and work more effectively.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In ‘Episode 2' of the series “Effective performance and personal success”, Assoc. Prof. Juan Luis Vásquez (DK) and Mr. Jason Howlett (DK) dive into the topic of energy management.They discuss how optimising physical, mental and emotional energy can lead to sustained high performance and overall well-being. The episode covers key factors such as sleep, movement, and recovery, along with strategies to manage stress and prevent burnout. The speakers also share practical techniques for maintaining focus and productivity throughout the day.Join us for an insightful conversation on how to manage your energy effectively and perform at your best.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In ‘Episode 1' of the series “Effective performance and personal success”, Assoc. Prof. Juan Luis Vásquez (DK) and Mr. Jason Howlett (DK) discuss the crucial topic of time management.They explore how effective prioritisation, planning and structured workflows can improve both productivity and personal success. The discussion covers practical strategies for optimising daily schedules, managing competing demands, and maintaining focus amid distractions. The speakers also share their perspectives on overcoming common time management challenges and building sustainable habits for long-term efficiency.Join us for an insightful conversation filled with actionable advice to help you take control of your time!For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this episode, UROONCO kidney cancer chief editor Dr. Carmen Mir talks to Assoc. Prof. Tian Zhang from UT Southwestern Medical Center (USA). Assoc. Prof. Zhang shares an overview on the trial results of metastatic kidney cancer (mRCC) that were discussed at ASCO GU25. These trials include CheckMate-9ER, COSMIC-313, KEYMAKER-U03, LITESPARK-011. Assoc. Prof. Zhang gives her expert opinion on how these trials could impact clinical practice on first-line kidney cancer treatment. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this podcast interview recorded at ASCO GU25, UROONCO bladder cancer chief editor Dr. Benjamin Pradere talked to Dr. Nadine Houede from CHU Nîmes, Hospital Caremeau in France, on the results of the iNDUCT trial. The iNDUCT trial is a phase II trial evaluated safety and efficacy of neoadjuvant chemotherapy (cisplatin or carboplatin + gemcitabine) in combination with durvalumab in these patients. Dr. Houede discusses the rational, the results and next steps. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
Welcome to another EAUN edition of EAU Podcasts! In this episode, Ms. Anna Mohammed and Ms. Marta Marchetti introduce the Special Interest Group (SIG) in Endourology and Robotics. Beginning with a brief introduction, Ms. Mohammed and Ms. Marchetti share details of what the SIG hopes to achieve, current developments, and how other nurse specialists can join the group.-----Hosts: Ms. Anna Mohammed – Originally from Trinidad, she graduated from the University of Hertfordshire in 2004. She began her career in theatre, progressing to Theatre Sister with a specialist interest in robotics, gynaecology, and urology. She later trained as a surgical care practitioner, earning a Master's in surgical care practice (urology) in 2015 and qualifying as an independent prescriber in 2021. Passionate about education, she has developed training for theatre staff and surgical practitioners. As Chair of the Endourology and Robotics SIG with the EAUN, she promotes evidence-based practice internationally. She currently works at Cleveland Clinic, London (GB).Ms. Marta Machetti – A skilled nursing professional from northern Italy, Marta graduated in Nursing from the University of Padua in 2013 and earned a Master's in the Surgical Treatment of Congenital Heart Disease in 2015. She advanced from a surgical nurse to a scrub nurse in endourology and robotics, later becoming a surgical assistant. In 2022, she completed a Master's in Surgical Care Practice at Anglia Ruskin University. Her expertise covers all surgical phases, and she is dedicated to staff and patient education. Actively involved in the EAUN, she now works at The Royal Marsden Hospital in Chelsea, a leading cancer treatment and research center.
In this episode, Dr. Nazim Gherabi (DZ) discusses his systematic review on the treatment of urge incontinence in postmenopausal women.Dr. Gherabi talks about the most effective therapeutic approaches, and evaluates current evidence. He highlights gaps in research and offers insights into tailoring treatments to improve patient outcomes. This episode provides valuable perspectives for clinicians and researchers interested in advancing care for this prevalent condition in postmenopausal women.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this episode, Dr. Benjamin Pradere (FR) interviews Dr. Markus Eckstein (DE) to explore how artificial intelligence is revolutionising the field of bladder cancer pathology.The discussion focuses on the role of AI in deciphering tumour complexity, improving diagnostic accuracy, and enhancing our understanding of this challenging disease. Dr. Eckstein shares insights into recent advancements, potential clinical applications, and the challenges of integrating AI into routine pathology workflows. This episode offers a compelling look at the intersection of technology and medicine, highlighting the future of AI-driven solutions in oncology.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this episode, Dr. Alexander Glaser (US) explores the relationship between genetic predisposition and lifestyle in benign prostatic hyperplasia (BPH).Drawing on data from a UK Biobank cohort study, he investigates whether varying levels of physical activity can modulate genetic risk factors for BPH. Dr. Glaser provides a detailed overview of the study's methodology, key findings, and potential implications for preventive and personalised approaches to managing prostate health. This episode sheds light on the critical intersection of genetics and lifestyle in addressing urological conditions.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
At the Turin Oncology Prostate Cancer Masterclass, UROONCO prostate cancer chief editor Dr. Giancarlo Marra talked to Prof. Bernardo Rocco from the Policlinico Gemelli and Università Cattolica in Rome (IT), on the new robotic technologies in prostate cancer, especially the technology of telesurgery and training. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
The UROONCO RCC editorial board chief editor Dr. Carmen Mir, and associate editors Dr. Teele Kuusk and Dr. Riccardo Bertolo share highlights of the important kidney cancer developments for 2024. They summarise the results on several important trials such as FASTRACK, ZIRCON, KEYNOTE-564 and IMmotion010. They also discuss the developments on surgical aspects too.To learn more on the highlights discussed in this podcast, you can read the below Articles of the Month, listen to the podcasts or watch the videos.Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptideASCO2024 special: Circulating kidney injury molecule-1 biomarker analysis in IMmotion010Present and future of robotic surgery for RCCThe treatment of locally advanced and metastatic renal cancerFor more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, Google Podcasts.
In 'Episode 7' of the series "Exploring urology: A roadmap for medical students", Assoc. Prof. Juan Gómez Rivas (ES) and Mrs. Sarah Collen (BE) discuss "Opportunities beyond the clinic – leadership, academia, and advocacy".They highlight how urologists can shape the future of healthcare by taking on leadership roles, contributing to academic research, and championing patient advocacy on a global scale. With their experiences, they discuss the rewards and challenges of pursuing these non-clinical avenues. Whether guiding institutional strategy, advancing cutting-edge research, or influencing policy for better urological care, these opportunities add depth and purpose to a urologist's career. This episode invites medical students to envision a broader, impactful future in urology that goes beyond the operating room.Whether you're considering urology as a career or are simply curious, listen in as we uncover why urology is an essential part of modern healthcare - and an exciting career path!For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In 'Episode 6' of the series on "Exploring urology: A roadmap for medical students", Prof. Michiel Sedelaar (NL) and Prof. Ian Pearce (GB) discuss "A day in the life of a urologist".This engaging conversation covers the multifaceted nature of urological practice, exploring the balance between clinical care, surgeries, research, and patient interaction. By sharing their personal experiences, Prof. Sedelaar and Prof. Pearce aim to inspire and inform students considering urology as a future career. Their dialogue offers a realistic, yet exciting glimpse into the profession, illustrating the profound impact a urologist can make on patients' lives.Whether you're considering urology as a career or are simply curious, listen in as we uncover why urology is an essential part of modern healthcare - and an exciting career path!For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In 'Episode 5' of the series on "Exploring urology: A roadmap for medical students", Prof. Marcio Moschovas (US) and Dr. Angelo Territo (IT) discuss "Cutting-edge technology and innovations in urology".They explore the rapid advancements in urological practices, highlighting the pivotal role of robotic surgery in improving surgical outcomes and enhancing precision.The episode offers insights into how these technologies are reshaping the urological landscape, making complex procedures less invasive and more patient-centred. From discussing their personal experiences with robotic systems to examining how innovations are driving the field forward, this episode provides a compelling look into the future of urology.Whether you're considering urology as a career or are simply curious, listen in as we uncover why urology is an essential part of modern healthcare - and an exciting career path!For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In 'Episode 4' of the series on "Exploring urology: A roadmap for medical students", Prof. James N'Dow (GB) and Dr. Paweł Rajwa (PL) discuss "Urological research and clinical trials".Together, they discuss the critical role of research in advancing urological care, offering insights into the complexities of clinical trials and their impact on patient outcomes. Prof. N'Dow and Dr. Rajwa share their experiences in the field, emphasising the need for curiosity and a dedication to evidence-based medicine.Whether you're considering urology as a career or are simply curious; Listen in as we uncover why urology is an essential part of modern healthcare - and an exciting career path!For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In episode 3 of the series "Exploring urology: A roadmap for medical students", Ass. Prof. Giancarlo Marra (IT) and Dr. Rossella Nicoletti (IT) discuss "Urology as a career choice".This is an enthusiastic talk about the unique appeal of urology, highlighting its dynamic mix of surgical precision, patient-focused care, and opportunities for innovation. Ass. Prof. Marra and Dr. Nicoletti address common misconceptions about the specialty, explore diverse career paths, and share practical advice on training and mentorship. With insights into the rewards and challenges of urology, this episode aims to inspire and guide medical students as they consider their future in this exciting field.
In 'Episode 2' of the series on "Exploring urology: A roadmap for medical students", Dr. Roderick Van Den Bergh (NL) and Dr. Katharina Beyer (NL) speak about "The impact of urology on public health". Dr. Van Den Bergh and Dr. Beyer discuss the importance of urology in public health, emphasising early diagnosis and treatment for common diseases such as kidney stones and various cancers. They also highlight the role of organisations like the European Association of Urology in raising global awareness and supporting prevention initiatives. The episode concludes with insights into understanding and addressing the educational needs of different populations concerning urological health.Join us as we uncover why urology is not only an essential part of modern healthcare but also a dynamic and rewarding career choice.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
Prof. Jens Bedke (DE) talks about two key topics from this year's EMUC24 kidney cancer sessions: the role of cytoreductive nephrectomy, and the SUNNIFORECAST trial (prospective randomised phase 2 trial of ipilimumab + nivolumab versus standaard of care in non-clear cell RCC.)This informative episode was recorded at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24) in Lisbon, Portugal. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In 'Episode 1' of the series on "Exploring urology: A roadmap for medical students", Prof. Henk Van der Poel (NL) and Dr. Alexander Ng (GB) introduce the field of urology, offering insights into its broad scope and unique appeal.In "Introduction to urology" Prof. Van der Poel and Dr. Ng discuss how urology combines surgical precision with medical innovation, covering everything from common treatments to advanced technologies that improve patient care. Highlighting urology's pivotal role in healthcare, they emphasise the opportunities for specialisation and close collaborations with other disciplines. Join us as we uncover why urology is not only an essential part of modern healthcare but also a dynamic and rewarding career choice.
At ICS24 (International Continence Society Annual Meeting), Dr. José Batista (ES) presented his abstract, “Artificial intelligence to read urodynamic tracings: Could we skip a human reading?”. In this episode of EAU Podcasts, Dr. Batista discusses the rationale and key findings of his study, exploring whether AI can interpret CMG traces reliably enough to be integrated into daily clinical practice.To learn more on this study, read the abstract here.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this interview from UROonco24, Dr. Juan Gómez Rivas (ES) and Dr. Ursula Vogl (CH) discuss advancements in genomic profiling and the use of PARP inhibitors in treating metastatic prostate cancer, with a focus on genomic profiling, patient selection and toxicity management.This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this episode, Dr. Martin Stentebjerg Skøtt (DK) presents findings from a recently published systematic review on the topic of "Endoscopic balloon dilatation and incision for treating primary obstructive megaureter in children".Historically, ureteral re-implantation has been the gold standard for addressing primary obstructive megaureter (POM) in children, but its challenges, particularly in infants, have spurred interest in less invasive methods. Dr. Skott discusses the effectiveness, safety, and benefits of endoscopic management as an alternative to the traditional surgical approach.Dr. Skøtt also discussses potential complications, the need for long-term follow-up, and the importance of future research to refine treatment protocols for better patient outcomes.Join us for this insightful conversation as Dr. Martin Skott sheds light on cutting-edge approaches to managing primary obstructive megaureter in children. Tune in and stay informed!
In this interview, medical oncologist Dr. Elena Castro (ES) and Dr. Gianluca Giannarini (IT) discuss the challenges of managing treatment-related toxicity and quality of life for PCa patients, particularly hormone-sensitive patients. This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
In this interview recorded at UROonco24 in Budapest earlier in the year, Dr. Gianluca Giannarini (IT) talks with Prof. Geert De Meerleer (BE) about the quality of life for patients with metastatic prostate cancer (mPCa) that are undergoing treatment. Their conversation features the role and safety of radiation therapy in patients with de novo metastatic hormone sensitive prostate cancer.This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.
In 'Episode 3' of the series "Voices of tomorrow's urologists (ESRU): Journeying through Europe's resident perspectives", Dr. Enrico Checcucci (IT) and Assoc. Prof. Stefano Puliatti (IT) discuss "Surgical training unveiled: Exploring new tech and standardisation trends".This insightful talk highlights the evolving landscape of urological surgical training, addressing the integration of new technologies such as 3D printing and virtual simulators. The conversation also underscores the need for standardised training pathways and explores the challenges posed by the heavy reliance on patient-based training in the early stages of the learning curve.Dr. Checcucci shares key findings from a Europe-wide survey on surgical training, shedding light on the current gaps and future directions. The episode offers valuable perspectives on how young urologists can benefit from a more structured and technologically enhanced training environment to ensure better surgical outcomes.
This EAU podcast has been developed with financial support from Pfizer Inc for healthcare professionals based in the EU and UK. The content discussed here was up to date at the time of recording in June 2024 and may not be suitable in your local market. The EAU has retained full editorial control.In this episode, the panel chair of the EAU guidelines on prostate cancer, Prof. Philip Cornford (GB) is at UROonco24 in Budapest, and talks to medical oncologist Dr. Ursula Vogl (CH) on the role of genetic testing for prostate cancer.Dr. Vogl discusses why genetic testing is important, and defines both somatic (tissue) testing, and germline testing. She shares her opinion on why ideally both should be done, and when, as well as an explanation of the guidelines.To keep updated on prostate cancer developments, go to the UROONCO Prostate Cancer Educational Platform. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.PP-UNP-GBR-10244. September 2024
In this podcast recorded live at ESMO 2024 in Barcelona, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Prof. Hiroshi Kitamura (JP) about his presentation on the JCOG1019 study results: An open-label, non-inferiority, randomised phase III study comparing the effectiveness of watchful waiting (WW) and intravesical Bacillus Calmette-Guérin (BCG) in patients with high-grade pT1 (HGT1) bladder cancer with pT0 on the second transurethral resection (TUR) specimen.Prof. Kitamura shares details of the study rationale, summarises the results, and discusses how these results could be implemented into clinical practice.
UROONCO BCa chief editor Dr. Benjamin Pradere talks to Assoc. Prof. Andrea Necchi (IT) at EMSO 2024 on the results of the interim analysis of SunRISe-4 study: TAR-200 plus cetrelimab or CET alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or refuse neoadjuvant cisplatin-based chemotherapy. Assoc. Prof. Necchi shares details of the study rationale and design, followed by an analysis of the results, and how these data could positively impact the future of treatment options for patients. According to Assoc. Prof. Necchi, the SunRISe-4 study results show for the first time that an intravesical treatment with TAR-200, combined with a systemic PD-1 inhibitor, could potentially result in a complete pathological response in a high proportion of patients.
In 'Episode 2' of the series on "Voices of tomorrow's urologists (ESRU): Journeying through Europe's resident perspectives", Dr. Chechilia Maria Cracco and Dr. Luis Enrique Ortega Polledo discuss "Inside endourology: Resident perspectives exposed".Hear about the unique challenges and rewarding experiences residents encounter in the specialised field of endourology. This discussion highlights the innovations shaping this area, offering insight into the learning process that residents undergo. Listeners will hear about endourology training and what residents find most engaging in their daily work. This episode provides a closer look at the evolving techniques and technology in urology, from the perspective of future specialist.
In this episode on "Prostate cancer indication for biopsy and screening", Dr. Roderick van den Bergh (NL) and Dr. Erik Briers (BE) discuss the dynamics of prostate cancer diagnostics, and the latest advancements in screening methods, including the updates to diagnostic algorithms that are reshaping clinical practices.The discussion covers the role of prostate biopsies in detecting cancer, focusing on when they are most beneficial and how they impact patient outcomes. Dr. Briers also shares insights from the patient perspective, emphasising the importance of informed decision-making.
In this episode recorded during the EAU Robotic Urology Section meeting 2024, Mr. Ben Challacombe (Guy's & St Thomas' MDM Urological Cancer and Clinical Robotics Lead, a UK Robotic Surgery Mentor and Robotic Fellowship Director) spoke to UROONCO RCC Associate Editor Dr. Riccardo Bertolo about robotic resection of renal cell carcinoma recurrence.Mr. Challacombe provided his strategy on how to plan a treatment if the recurrence takes place after partial nephrectomy. He offered insights into the more appropriate treatment (robotic nephron-sparing approach vs. radical nephrectomy vs. ablation) based on the characteristics of the recurrence. He also shared his experiences regarding the status of tissues encountered during such surgeries after the patient is exposed to systemic therapy or radiation. Finally, he shared important insights about the different multi-port and single-port platforms available on the European market, and the choice among them, particularly if such complex surgical interventions must be performed.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, Google Podcasts.
In this episode on "How to handle adverse events after instillation therapy," Prof. Alexandra Masson-Lecomte (FR) and Prof. Fred Witjes (NL) discuss a case that highlights the challenges healthcare providers face when managing post-treatment complications. They explore adverse reactions, underlying causes, and strategies to mitigate these effects while ensuring optimal patient outcomes. They also talk about best practices for early identification and intervention, drawing from their extensive clinical experience and current research.Whether you are a seasoned clinician or a healthcare professional looking to expand your knowledge, this episode offers valuable insights into the complexities of instillation therapy management. Tune in as we examine how to enhance patient safety and improve therapeutic efficacy through informed decision-making and practical solutions.AcknowledgmentThis activity is supported by an educational grant from our industry partner, with no involvement in the programme or speaker selection.
In 'Episode 1' of the series on "Voices of tomorrow's urologists (ESRU): Journeying through Europe's resident perspectives", Dr. Vital Hevia Palacios and Dr. Alessio Pecoraro discuss "Into the OR: Residents' role in kidney transplants". This episode takes a look at the valuable contributions urology residents can make during kidney transplant surgeries. Dr. Hevia Palacios and Dr. Pecoraro share their firsthand experiences, shedding light on the challenges and opportunities that come with this vital training. Their conversation provides insights into the evolving role of residents in transplantation, highlighting the importance of hands-on experience in shaping the next generation of urologists.
In "Episode 4" of the series on "What young urologists need to know", segment 3 covers the topic of "Pursuing academic excellence in urology".In this episode, "Starting your journey in urology research and academics", Prof. Bhaskar Somani (GB) and Dr. Robert Geraghty (GB) discuss the essential steps for newcomers to the field. They share practical advice on how to begin a career in urology research, from identifying research opportunities to finding mentors. The conversation covers the importance of academic publishing and tips for networking in the urology community.Whether you're a student or a clinician looking to transition into research, this episode offers valuable insights. Tune in to learn how to build a successful academic career in urology.
Welcome to the fourth episode of "Andrology chronicles: Messages for men's health", a podcast series accredited by the EU-ACME programme.In this final episode, titled "Navigating priapism. Tailored approaches for both ischaemic and non-ischaemic cases", the complexities of diagnosing and managing priapism are explored. Our distinguished speakers, Dr. R. Rees (GB) and Dr. V. Sahdev (GB), provide a comprehensive overview of both ischaemic (low-flow) and non-ischaemic (high-flow) priapism, discussing their distinct etiologies and clinical presentations. They share details on the latest treatment protocols, from emergency interventions to long-term management strategies, ensuring that healthcare professionals are well-equipped to handle these critical situations.This episode is the last in a series of four. Past episodes include:The varicocele conundrum. Treatment strategies explored - already released, find it here.The complex Peyronie's dilemma. Methods for effective management - already released, find it here.From investigation to resolution. Tackling advanced erectile dysfunction - already released, find it here.This series is essential listening for healthcare professionals dedicated to advancing men's health, as well as for patients seeking comprehensive knowledge about their conditions. Tune in to enhance your understanding and stay at the forefront of andrological care.Upon completion of all four episodes and a post-test questionnaire, listeners will receive 1 European CME credit (ECMEC®) upon completion.Here is the post-test questionnaire for this episode.
Welcome to the third episode of "Andrology chronicles: Messages for men's health", the podcast series accredited by the EU-ACME programme.In this episode, titled "From investigation to resolution. Tackling advanced erectile dysfunction (ED)", experts Dr. R. Rees (GB) and Dr. V. Sahdev (GB) will take you through a thorough exploration of diagnostic techniques and cutting-edge treatment options. They will examine the underlying causes of advanced ED, ranging from physiological to psychological factors, and discuss the latest advancements in pharmacological treatments, surgical interventions, and lifestyle modifications.This episode is the third in a series of four. Past or future episodes include:The varicocele conundrum. Treatment strategies explored - already released, find it here.The complex Peyronie's dilemma. Methods for effective management - already released, find it here.Navigating priapism: Tailored approaches for both ischaemic and non-ischaemic cases - releasing on August 18th.This series is essential listening for healthcare professionals dedicated to advancing men's health, as well as for patients seeking comprehensive knowledge about their conditions. Tune in to enhance your understanding and stay at the forefront of andrological care.Upon completion of all four episodes and a post-test questionnaire, listeners will receive 1 European CME credit (ECMEC®) upon completion.Sign in for the post-test questionnaire for this episode.
Welcome to the second episode of "Andrology chronicles: Messages for men's health", a podcast series accredited by the EU-ACME programme.In this episode, titled "The complex Peyronie's dilemma: Methods for effective management", we address the challenges and treatment options for Peyronie's disease, a condition characterised by the development of fibrous scar tissue inside the penis. Dr. R. Rees (GB) and Dr. V. Sahdev (GB) will guide you through the latest advancements in medical and surgical treatments, as well as innovative non-invasive approaches. They will explore the implications of Peyronie's disease on sexual health and quality of life, providing a comprehensive understanding of patient management strategies.This episode is the second in a series of four. Past or future episodes include:The varicocele conundrum. Treatment strategies explored - already released, find it here.From investigation to resolution: Tackling advanced erectile dysfunction - releasing on August 11th.Navigating priapism: Tailored approaches for both ischaemic and non-ischaemic cases - releasing on August 18th.This series is essential listening for healthcare professionals dedicated to advancing men's health, as well as for patients seeking comprehensive knowledge about their conditions. Tune in to enhance your understanding and stay at the forefront of andrological care.Upon completion of all four episodes and a post-test questionnaire, listeners will receive 1 European CME credit (ECMEC®) upon completion.Sign in for the post-test questionnaire for this episode.